| Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism A Sonmez, C Haymana, E Bolu, A Aydogdu, S Tapan, M Serdar, B Altun, ... European Journal of Endocrinology 164 (5), 759-764, 2011 | 51 | 2011 |
| High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome A Aydogdu, I Tasci, S Tapan, Y Basaran, U Aydogan, C Meric, A Sonmez, ... Gynecological Endocrinology 28 (9), 722-725, 2012 | 36 | 2012 |
| It is not diabetic foot: it is my foot M Meriç, G Ergün, C Meriç, İ Demirci, Ö Azal Journal of wound care 28 (1), 30-37, 2019 | 32 | 2019 |
| Initial experience of 3 tesla apparent diffusion coefficient values in differentiating benign and malignant thyroid nodules AT Ilica, H Artaş, A Ayan, A Günal, O Emer, Z Kilbas, C Meric, MM Atasoy, ... Journal of Magnetic Resonance Imaging 37 (5), 1077-1082, 2013 | 30 | 2013 |
| Efficacy of plasmapheresis in the treatment of refractory toxic epidermal necrolysis-like acute cutaneous lupus erythematosus I Simsek, M Cinar, H Erdem, S Pay, C Meric, A Dinc Lupus 17 (6), 605, 2008 | 18 | 2008 |
| Effects of three different medications on metabolic parameters and testicular volume in patients with hypogonadotropic hypogonadism: 3‐year experience A Aydogdu, E Bolu, A Sonmez, I Tasci, C Haymana, R Acar, C Meric, ... Clinical endocrinology 79 (2), 243-251, 2013 | 16 | 2013 |
| Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging 18 F-FDG … K Okuyucu, S Ince, E Alagoz, O Emer, H San, E Balkan, A Ayan, C Meric, ... Hell J Nucl Med 19 (3), 208-217, 2016 | 15 | 2016 |
| HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism E Bolu, A Sonmez, S Tapan, A Taslipinar, A Aydogdu, C Meric, Y Basaran, ... Hormone and Metabolic Research 45 (06), 443-448, 2013 | 15 | 2013 |
| Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement A Sonmez, C Haymana, A Aydogdu, S Tapan, Y Basaran, C Meric, ... Endocrine Journal 62 (7), 605-613, 2015 | 14 | 2015 |
| Osteoprotegerin, fibroblast growth factor 23, and vitamin D3 levels in male patients with hypogonadism C Meric, A Sonmez, A Aydogdu, S Tapan, C Haymana, Y Basaran, ... Hormone and Metabolic Research 46 (13), 955-958, 2014 | 12 | 2014 |
| Oxidative stress status in congenital hypogonadism: an appraisal C Haymana, A Aydoğdu, B Soykut, O Erdem, T Ibrahimov, M Dinc, ... Toxicology mechanisms and methods 27 (6), 451-457, 2017 | 11 | 2017 |
| Visceral adiposity index and triglyceride/high-density lipoprotein cholesterol ratio in hypogonadism C Haymana, A Sonmez, A Aydogdu, S Tapan, Y Basaran, C Meric, ... Archives of Endocrinology and Metabolism 61, 282-287, 2017 | 11 | 2017 |
| Triglyceride-glucose index levels in patients with congenital hypogonadotropic hypogonadism and the relationship with endothelial dysfunction and insulin resistance I Demirci, C Haymana, B Candemir, C Meric, B Yuksel, M Eser, O Akın, ... Endokrynologia Polska 72 (3), 232-237, 2021 | 10 | 2021 |
| Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity? A Aydogdu, I Tasci, S Tapan, A Sonmez, U Aydogan, H Akbulut, G Uckaya, ... Experimental and clinical endocrinology & diabetes, 261-265, 2012 | 10 | 2012 |
| Accuracy of recall of the items included in disease activity forms of Behçet’s disease: comparison of retrospective questionnaires with a daily telephone interview I Simsek, C Meric, H Erdem, S Pay, S Kilic, A Dinc Clinical rheumatology 27, 1255-1260, 2008 | 10 | 2008 |
| Effect of testosterone replacement therapy on vitamin D and FGF-23 levels in congenital hypogonadism C Haymana, A Sonmez, A Aydogdu, S Tapan, Y Basaran, C Meric, ... Endokrynologia Polska 68 (3), 311-616, 2017 | 8 | 2017 |
| Zoledronic acid use and risk of cognitive decline among elderly women and men with osteoporosis I Tasci, U Safer, U Cintosun, E Bozoglu, I Naharci, A Aydogdu, C Meric, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2016 | 7 | 2016 |
| Increased endothelial dysfunction and insulin resistance in patients with Klinefelter syndrome C Haymana, A Aydogdu, I Demirci, M Dinc, O Demir, D Torun, F Yesildal, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2018 | 6 | 2018 |
| Add on exenatide treatment is beneficial in poorly controlled obese type 2 diabetics under intensive insulin regimens A Sönmez, M Dinç, A Taşlıpınar, A Aydoğdu, C Meric, Y Başaran, ... Experimental and Clinical Endocrinology & Diabetes 125 (04), 256-261, 2017 | 6 | 2017 |
| Hipertansiyon tanı ve tedavi kılavuzu M Aşık, A Aydoğdu, F Bayram, H Bilen, S Can, M Cesur, İ Çakır, O Dikbaş, ... Ankara: Miki Matbaacılık, 1-5, 2018 | 5 | 2018 |
